Taigen Biopharmaceuticals Holdings Ltd (4157) — Net Asset Quality Index
Taigen Biopharmaceuticals Holdings Ltd (4157) has a Net Asset Quality Index of 92.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$1.17 Billion minus total liabilities of NT$92.38 Million yields net assets of NT$1.07 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See defensive interval ratio of Taigen Biopharmaceuticals Holdings Ltd to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Taigen Biopharmaceuticals Holdings Ltd Net Asset Quality Index Over Time (2010–2025)
This chart shows how Taigen Biopharmaceuticals Holdings Ltd's Net Asset Quality Index has evolved across 16 annual periods from 2010 to 2025. As of December 2025, the index stands at 92.1%, representing net assets of NT$1.07 Billion against total assets of NT$1.17 Billion TWD. Explore Taigen Biopharmaceuticals Holdings Ltd (4157) cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Taigen Biopharmaceuticals Holdings Ltd (2010–2025)
The table below presents the year-by-year Net Asset Quality Index for Taigen Biopharmaceuticals Holdings Ltd from 2010 to 2025, covering 16 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Taigen Biopharmaceuticals Holdings Ltd (4157) total market value.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.1% | NT$1.07 Billion | NT$1.17 Billion | NT$92.38 Million | ▼ -0.1 pp |
| 2024 | 92.2% | NT$1.08 Billion | NT$1.17 Billion | NT$91.96 Million | ▲ +1.2 pp |
| 2023 | 91.0% | NT$1.12 Billion | NT$1.23 Billion | NT$110.94 Million | ▼ -1.7 pp |
| 2022 | 92.6% | NT$970.03 Million | NT$1.05 Billion | NT$76.98 Million | ▲ +2.6 pp |
| 2021 | 90.0% | NT$1.25 Billion | NT$1.39 Billion | NT$139.11 Million | ▲ +10.5 pp |
| 2020 | 79.5% | NT$442.18 Million | NT$556.45 Million | NT$114.26 Million | ▼ -6.7 pp |
| 2019 | 86.2% | NT$815.18 Million | NT$946.11 Million | NT$130.92 Million | ▼ -5.9 pp |
| 2018 | 92.1% | NT$1.09 Billion | NT$1.19 Billion | NT$94.36 Million | ▼ -1.5 pp |
| 2017 | 93.6% | NT$1.42 Billion | NT$1.52 Billion | NT$97.71 Million | ▲ +11.5 pp |
| 2016 | 82.0% | NT$675.62 Million | NT$823.45 Million | NT$147.82 Million | ▲ +11.4 pp |
| 2015 | 70.6% | NT$441.60 Million | NT$625.46 Million | NT$183.86 Million | ▼ -7.0 pp |
| 2014 | 77.6% | NT$852.14 Million | NT$1.10 Billion | NT$246.05 Million | ▲ +46.0 pp |
| 2013 | 31.6% | NT$153.77 Million | NT$486.49 Million | NT$332.71 Million | ▼ -19.2 pp |
| 2012 | 50.8% | NT$372.80 Million | NT$733.95 Million | NT$361.15 Million | ▼ -33.3 pp |
| 2011 | 84.1% | NT$513.21 Million | NT$610.52 Million | NT$97.31 Million | ▲ +469.5 pp |
| 2010 | -385.4% | NT$-4.29 Billion | NT$1.11 Billion | NT$5.40 Billion | — |